Is It The Vax? Peru Declares ‘National Health Emergency’ as Guillain-Barre Cases Surge

The South American country of Peru has declared a nationwide emergency as it experiences a bizarre outbreak of Guillain-Barré Syndrome (GBS), prompting many to suspect the experimental Covid-19 vaccine could be to blame as most of the country’s populace received the jab.

Peru’s Health Ministry announced the 90-day emergency on Saturday citing an “unusual increase” in GBS cases.

“Since June 2023, 182 cases have been reported nationwide, of which 147 have been discharged, 31 remain hospitalized, and four have died,” reported South American media MercoPress News on Monday.

According to the National Institutes of Health, Guillain-Barré “is a rare neurological disorder in which your immune system mistakenly attacks part of the peripheral nervous system—the network of nerves located outside of the brain and spinal cord.”

Guillain-Barré has a long history of being a severe adverse reaction associated with several vaccines, including the swine flu vaccine of 1976 which led to thousands of GBS cases and over 25 deaths in the US.

The debilitating neurological vaccine side effect again reared its ugly head as the FDA held a virtual meeting evaluating the experimental Covid-19 jab for public use.

At one point during a slideshow presentation regarding the jab in October 2020 – two months before it was released to the public – the FDA inadvertently flashed on-screen a draft list of Covid-19 vaccine “possible adverse event outcomes,” the first of which was “Guillain Barré syndrome.”

GBS cases were so prevalent following the Covid jab rollout that vaccine manufacturer Johnson & Johnson was ordered by the FDA to add a warning acknowledging Guillain-Barré was a known possible adverse reaction.

GBS cases have also been observed in recipients of the Pfizer, Moderna and AstraZeneca jabs.

The disorder’s history of being associated with vaccines, in addition to the country’s extremely high coronavirus vaccination rate, prompted many on social media to speculate the jab could be behind the GBS spike.